Monkeypox is a rare viral disease caused by the monkeypox virus, which is related to the smallpox virus. It can cause a rash and flu-like symptoms and is usually self-limiting, though severe cases can occur. It spreads through close contact with an infected person, animal, or contaminated materials.
Causes of Monkeypox
Monkeypox is caused by the monkeypox virus, a member of the Orthopoxvirus genus. It was first discovered in monkeys but is also found in rodents and can be transmitted to humans.
How Monkeypox Spreads
- Direct contact with skin lesions or bodily fluids of an infected person
- Respiratory droplets during prolonged face-to-face contact
- Touching contaminated objects like bedding, clothing, or surfaces
- Animal-to-human transmission through bites, scratches, or contact with animal fluids
Monkeypox is not as contagious as COVID-19 and typically requires close or intimate contact to spread.
Symptoms of Monkeypox
Symptoms usually begin within 5–21 days after exposure and may include:
- Fever
- Headache
- Muscle aches
- Back pain
- Swollen lymph nodes
- Chills
- Fatigue
- A characteristic rash, often starting on the face and spreading to other parts of the body
- The rash turns into fluid-filled blisters, then scabs over and heals
Duration and Course
- Illness usually lasts 2 to 4 weeks
- Most people recover fully without treatment
- Severe cases may occur, especially in immunocompromised individuals or children
Diagnosis
- Based on symptoms, travel history, and exposure risks
- Confirmed through laboratory testing of lesions or fluids (PCR test)
Treatment
- Most cases resolve with supportive care (rest, fluids, and symptom relief)
- Antiviral medications (like tecovirimat) may be used in severe cases
- Vaccination (smallpox or monkeypox vaccines) can help prevent or reduce severity
Prevention
- Avoid close contact with infected individuals or animals
- Wash hands frequently
- Use personal protective equipment (PPE) in healthcare or outbreak settings
- Isolate infected individuals until fully healed
- Vaccination for at-risk groups


